JAS Sees “No Need” to Change Its Guidelines in Response to 2013 ACC/AHA Guidelines for the Prevention of ASCVD

The Japan Atherosclerosis Society (JAS) announced on February 2 its views on the guidelines for the management of serum lipid levels to prevent atherosclerotic cardiovascular disease (ASCVD) announced by the American College of Cardiology (ACC) and the American Heart Association...read more